http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105884863-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B82Y30-00 |
| filingDate | 2014-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105884863-B |
| titleOfInvention | LPNISKP-modified 1-acetyl-β-carbolinoyl-tryptophan, its preparation, nanostructure, activity and application |
| abstract | The present invention discloses 1-acetyl-β-carboline-yl-tryptophan modified by LPNISKP of the following structure, LPNISKP is Leu-Pro-Asn-Ile-Ser-Lys-Pro in the structure, Leu-Pro-Asn-Ile The formal abbreviation of ‑Ser‑Lys‑Pro, discloses its preparation method, discloses its nanostructure, discloses its anti-tumor cell adhesion effect, discloses its anti-tumor cell invasion effect, and discloses its anti-tumor The function of cell migration discloses its anti-tumor effect, and further discloses its function of inhibiting tumor metastasis to the lung. Thus the present invention discloses its application in medicine. |
| priorityDate | 2014-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 66.